• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Omeros Corporation - Common Stock (NQ:OMER)

    14.77 +0.21 (+1.44%)
    Streaming Delayed Price Updated: 1:38 PM EDT, Apr 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 322,365
    Open 14.72
    Bid (Size) 14.76 (100)
    Ask (Size) 14.78 (300)
    Prev. Close 14.56
    Today's Range 14.61 - 14.92
    52wk Range 2.950 - 17.65
    Shares Outstanding 62,855,824
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    These stocks are gapping in today's session ↗
    Via Chartmill

    Performance

    YTD
    -9.8%
    -9.8%
    1 Month
    +50.6%
    +50.6%
    3 Month
    +25.1%
    +25.1%
    6 Month
    +92.3%
    +92.3%
    1 Year
    +104.9%
    +104.9%

    More News

    Read More
    Omeros Corp (NASDAQ:OMER) Reports Q4 2025 Earnings Boosted by Major Asset Sale, Launches First Commercial Product ↗
    Via Chartmill
    News headline image
    Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
    From Omeros Corporation
    Via Business Wire
    News headline image
    Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
    From Omeros Corporation
    Via Business Wire
    News headline image
    Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
    From Omeros Corporation
    Via Business Wire
    News headline image
    Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
    From Omeros Corporation
    Via Business Wire
    News headline image
    Omeros Announces First Commercial Sales of YARTEMLEA®
    From Omeros Corporation
    Via Business Wire
    News headline image
    Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics ETFs Government Stocks
    News headline image
    Why Did Omeros Stock Jump 5% In After-Hours Trading Today? ↗
    Via Stocktwits
    News headline image
    Omeros Announces New Date for YARTEMLEA® Approval Conference Call
    From Omeros Corporation
    Via Business Wire
    News headline image
    Why Omeros Stock Skyrocketed Today ↗
    Via The Motley Fool
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter ↗
    Via Stocktwits
    Topics ETFs Economy Stocks
    News headline image
    Top movers in Wednesday's session ↗
    Via Chartmill
    News headline image
    Which stocks are gapping on Wednesday? ↗
    Via Chartmill
    News headline image
    Omeros Stock Jumps Premarket After FDA Approves First Drug For Rare Transplant Complication — Retail Sees Big Upside ↗
    Via Stocktwits
    News headline image
    FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
    From Omeros Corporation
    Via Business Wire
    News headline image
    Omeros Stock Garners High Retail Attention Ahead Of FDA Verdict For Life-Saving Drug ↗
    Via Stocktwits
    News headline image
    Omeros Corp Sells Immune-System Drug To Novo Nordisk In $2.1B Deal — Retail Shifts Focus To Narsoplimab FDA Call ↗
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
    From Omeros Corporation
    Via Business Wire
    News headline image
    Omeros (OMER) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Derivatives Earnings
    News headline image
    Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga

    Frequently Asked Questions

    Is Omeros Corporation - Common Stock publicly traded?
    Yes, Omeros Corporation - Common Stock is publicly traded.
    What exchange does Omeros Corporation - Common Stock trade on?
    Omeros Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Omeros Corporation - Common Stock?
    The ticker symbol for Omeros Corporation - Common Stock is OMER on the Nasdaq Stock Market
    What is the current price of Omeros Corporation - Common Stock?
    The current price of Omeros Corporation - Common Stock is 14.77
    When was Omeros Corporation - Common Stock last traded?
    The last trade of Omeros Corporation - Common Stock was at 04/30/26 01:38 PM ET
    What is the market capitalization of Omeros Corporation - Common Stock?
    The market capitalization of Omeros Corporation - Common Stock is 928.38M
    How many shares of Omeros Corporation - Common Stock are outstanding?
    Omeros Corporation - Common Stock has 928M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.